Sarah M. Weakley

1.8k total citations
21 papers, 1.4k citations indexed

About

Sarah M. Weakley is a scholar working on Molecular Biology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Sarah M. Weakley has authored 21 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 4 papers in Surgery and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Sarah M. Weakley's work include MicroRNA in disease regulation (3 papers), Circular RNAs in diseases (3 papers) and Aortic aneurysm repair treatments (2 papers). Sarah M. Weakley is often cited by papers focused on MicroRNA in disease regulation (3 papers), Circular RNAs in diseases (3 papers) and Aortic aneurysm repair treatments (2 papers). Sarah M. Weakley collaborates with scholars based in United States and Thailand. Sarah M. Weakley's co-authors include Qizhi Yao, Changyi Chen, Md Saha Jamaluddin, Peter H. Lin, Panagiotis Kougias, Lidong Zhang, Yuqing Zhang, Hao Wang, Jun Jiang and Carlos F. Bechara and has published in prestigious journals such as Journal of Nutrition, British Journal of Pharmacology and Molecular Cancer.

In The Last Decade

Sarah M. Weakley

21 papers receiving 1.3k citations

Peers

Sarah M. Weakley
Sarah M. Weakley
Citations per year, relative to Sarah M. Weakley Sarah M. Weakley (= 1×) peers Paweł Wołkow

Countries citing papers authored by Sarah M. Weakley

Since Specialization
Citations

This map shows the geographic impact of Sarah M. Weakley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah M. Weakley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah M. Weakley more than expected).

Fields of papers citing papers by Sarah M. Weakley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah M. Weakley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah M. Weakley. The network helps show where Sarah M. Weakley may publish in the future.

Co-authorship network of co-authors of Sarah M. Weakley

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah M. Weakley. A scholar is included among the top collaborators of Sarah M. Weakley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah M. Weakley. Sarah M. Weakley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lin, Peter H., Panagiotis Kougias, Sarah M. Weakley, et al.. (2012). Clinical Outcome of Staged Versus Combined Treatment Approach of Hybrid Repair of Thoracoabdominal Aortic Aneurysm With Visceral Vessel Debranching and Aortic Endograft Exclusion. Perspectives in Vascular Surgery. 24(1). 5–13. 31 indexed citations
2.
Lü, Jinhu, Sarah M. Weakley, Zhen Yang, et al.. (2012). Ginsenoside Rb1 Directly Scavenges Hydroxyl Radical and Hypochlorous Acid. Current Pharmaceutical Design. 18(38). 6339–6347. 42 indexed citations
3.
Lü, Jianming, Shaoyu Yan, Sarah M. Weakley, et al.. (2012). Ginkgolic acid inhibits HIV protease activity and HIV infection in vitro. Medical Science Monitor. 18(8). BR293–BR298. 54 indexed citations
4.
Jamaluddin, Md Saha, Sarah M. Weakley, Qizhi Yao, & Changyi Chen. (2011). Resistin: functional roles and therapeutic considerations for cardiovascular disease. British Journal of Pharmacology. 165(3). 622–632. 390 indexed citations
5.
Weakley, Sarah M., Xinwen Wang, Hong Mu, et al.. (2011). Ginkgolide A-Gold Nanoparticles Inhibit Vascular Smooth Muscle Proliferation and Migration In Vitro and Reduce Neointimal Hyperplasia in a Mouse Model. Journal of Surgical Research. 171(1). 31–39. 17 indexed citations
6.
Yang, Hui, Lidong Zhang, Sarah M. Weakley, et al.. (2011). Transforming growth factor-beta increases the expression of vascular smooth muscle cell Markers in human multi-lineage progenitor cells. Medical Science Monitor. 17(3). BR55–BR61. 12 indexed citations
7.
Jiang, Jun, et al.. (2011). Nordihydroguaiaretic acid (NDGA) inhibits ritonavir-induced endothelial dysfunction in porcine pulmonary arteries. Medical Science Monitor. 17(11). BR312–BR318. 3 indexed citations
8.
Obchoei, Sumalee, Sarah M. Weakley, Sopit Wongkham, et al.. (2011). Cyclophilin A enhances cell proliferation and tumor growth of liver fluke-associated cholangiocarcinoma. Molecular Cancer. 10(1). 102–102. 53 indexed citations
9.
Zhang, Lidong, Md Saha Jamaluddin, Sarah M. Weakley, Qizhi Yao, & Changyi Chen. (2011). Roles and Mechanisms of MicroRNAs in Pancreatic Cancer. World Journal of Surgery. 35(8). 1725–1731. 33 indexed citations
10.
Weakley, Sarah M., Jun Jiang, Jinhu Lü, et al.. (2011). Natural antioxidant dihydroxybenzyl alcohol blocks ritonavir-induced endothelial dysfunction in porcine pulmonary arteries and human endothelial cells. Medical Science Monitor. 17(9). BR235–BR241. 10 indexed citations
11.
Naoum, Joseph J., et al.. (2011). Complications of Tunneled Cuffed Hemodialysis Catheters in Patients with Human Immunodeficiency Virus Infection. The Journal of Vascular Access. 12(4). 341–347. 1 indexed citations
12.
Lin, Peter H., Sarah M. Weakley, & Panagiotis Kougias. (2010). How to Interpret Data from the Superficial Femoral Artery Stenting Trials and Registries. Seminars in Vascular Surgery. 23(3). 138–147. 10 indexed citations
13.
Chen, Changyi, Yuqing Zhang, Lidong Zhang, Sarah M. Weakley, & Qizhi Yao. (2010). MicroRNA‐196: critical roles and clinical applications in development and cancer. Journal of Cellular and Molecular Medicine. 15(1). 14–23. 178 indexed citations
14.
Jamaluddin, Md Saha, Sarah M. Weakley, Lidong Zhang, et al.. (2010). miRNAs: roles and clinical applications in vascular disease. Expert Review of Molecular Diagnostics. 11(1). 79–89. 70 indexed citations
15.
Weakley, Sarah M., Jun Jiang, Panagiotis Kougias, et al.. (2010). Role of somatic mutations in vascular disease formation. Expert Review of Molecular Diagnostics. 10(2). 173–185. 30 indexed citations
16.
Kougias, Panagiotis, Sarah M. Weakley, Qizhi Yao, Peter H. Lin, & Changyi Chen. (2010). Arterial baroreceptors in the management of systemic hypertension.. PubMed. 16(1). RA1–8. 57 indexed citations
17.
Weakley, Sarah M., Jun Jiang, Panagiotis Kougias, et al.. (2010). Molecular mechanisms and clinical applications of nordihydroguaiaretic acid (NDGA) and its derivatives: an update.. PubMed. 16(5). RA93–100. 116 indexed citations
18.
Wang, Xinwen, Sarah M. Weakley, Panagiotis Kougias, et al.. (2009). The Soybean Isoflavonoid Equol Blocks Ritonavir-Induced Endothelial Dysfunction in Porcine Pulmonary Arteries and Human Pulmonary Artery Endothelial Cells. Journal of Nutrition. 140(1). 12–17. 25 indexed citations
19.
Bechara, Carlos F., Sarah M. Weakley, Panagiotis Kougias, et al.. (2009). Percutaneous Treatment of Varicocele with Microcoil Embolization: Comparison of Treatment Outcome with Laparoscopic Varicocelectomy. Vascular. 17(3_suppl). 129–136. 33 indexed citations
20.
Lin, Peter H., Suman Annambhotla, Carlos F. Bechara, et al.. (2009). Comparison of Percutaneous Ultrasound-Accelerated Thrombolysis Versus Catheter-Directed Thrombolysis in Patients with Acute Massive Pulmonary Embolism. Vascular. 17(3_suppl). 137–147. 95 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026